11-32388003-AACACACACACACACACACAC-AACACACACACACACACACACAC
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_024426.6(WT1):c.*1053_*1054dupGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.040 ( 119 hom., cov: 0)
Exomes 𝑓: 0.037 ( 0 hom. )
Consequence
WT1
NM_024426.6 3_prime_UTR
NM_024426.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.29
Publications
2 publications found
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1 Gene-Disease associations (from GenCC):
- Denys-Drash syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P
- Wilms tumor 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Frasier syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0398 (5828/146512) while in subpopulation AMR AF = 0.0513 (754/14702). AF 95% confidence interval is 0.0483. There are 119 homozygotes in GnomAd4. There are 2694 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 5828 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WT1 | ENST00000452863.10 | c.*1053_*1054dupGT | 3_prime_UTR_variant | Exon 10 of 10 | 1 | NM_024426.6 | ENSP00000415516.5 |
Frequencies
GnomAD3 genomes AF: 0.0397 AC: 5819AN: 146396Hom.: 119 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
5819
AN:
146396
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0371 AC: 3052AN: 82374Hom.: 0 Cov.: 0 AF XY: 0.0370 AC XY: 1406AN XY: 38014 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
3052
AN:
82374
Hom.:
Cov.:
0
AF XY:
AC XY:
1406
AN XY:
38014
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
146
AN:
3884
American (AMR)
AF:
AC:
111
AN:
2504
Ashkenazi Jewish (ASJ)
AF:
AC:
76
AN:
5110
East Asian (EAS)
AF:
AC:
554
AN:
11474
South Asian (SAS)
AF:
AC:
7
AN:
696
European-Finnish (FIN)
AF:
AC:
13
AN:
750
Middle Eastern (MID)
AF:
AC:
16
AN:
488
European-Non Finnish (NFE)
AF:
AC:
1892
AN:
50680
Other (OTH)
AF:
AC:
237
AN:
6788
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.327
Heterozygous variant carriers
0
203
405
608
810
1013
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0398 AC: 5828AN: 146512Hom.: 119 Cov.: 0 AF XY: 0.0378 AC XY: 2694AN XY: 71250 show subpopulations
GnomAD4 genome
AF:
AC:
5828
AN:
146512
Hom.:
Cov.:
0
AF XY:
AC XY:
2694
AN XY:
71250
show subpopulations
African (AFR)
AF:
AC:
1569
AN:
40212
American (AMR)
AF:
AC:
754
AN:
14702
Ashkenazi Jewish (ASJ)
AF:
AC:
71
AN:
3390
East Asian (EAS)
AF:
AC:
121
AN:
4972
South Asian (SAS)
AF:
AC:
87
AN:
4560
European-Finnish (FIN)
AF:
AC:
204
AN:
9572
Middle Eastern (MID)
AF:
AC:
8
AN:
288
European-Non Finnish (NFE)
AF:
AC:
2808
AN:
65904
Other (OTH)
AF:
AC:
100
AN:
2028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
254
509
763
1018
1272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nephroblastoma Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
11p partial monosomy syndrome Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Meacham syndrome Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nephrotic syndrome, type 4 Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.